Safety and Immunogenicity of a Novel Vaccine Formulation MV-ZIKA-RSP (V187-001)
Clinical trial NCT04033068 · COMPLETED
Trial details
- NCT number
- NCT04033068
- Sponsor
- Themis Bioscience GmbH
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-02
- Primary completion
- 2020-01-30
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.